JANX |
Janux Therapeutics, Inc. |
Director, 10%+ Owner |
$482M |
+$119M |
+32.7% |
Oct 18, 2024 |
AVTE |
Aerovate Therapeutics, Inc. |
Director, 10%+ Owner |
$198M |
|
|
Jun 17, 2024 |
TYRA |
Tyra Biosciences, Inc. |
Director, 10%+ Owner |
$154M |
+$19.8M |
+14.7% |
Nov 8, 2024 |
ITOS |
iTeos Therapeutics, Inc. |
Former 10% Owner |
$137M |
+$100M |
+270% |
May 10, 2024 |
NKTX |
Nkarta, Inc. |
Director, 10%+ Owner |
$131M |
+$60M |
+85.1% |
Jun 13, 2024 |
CTKB |
Cytek Biosciences, Inc. |
Director, 10%+ Owner |
$127M |
|
|
Mar 14, 2022 |
ETNB |
89bio, Inc. |
Director, 10%+ Owner |
$111M |
+$48.3M |
+77.8% |
Nov 14, 2024 |
PEPG |
PepGen Inc. |
Director, 10%+ Owner |
$97.7M |
+$27.2M |
+38.6% |
Jun 20, 2024 |
SPRY |
ARS Pharmaceuticals, Inc. |
Director, 10%+ Owner |
$97.5M |
+$13.3M |
+15.8% |
Jun 20, 2024 |
FULC |
Fulcrum Therapeutics, Inc. |
10%+ Owner |
$79.4M |
|
|
Sep 12, 2024 |
FDMT |
4D Molecular Therapeutics, Inc. |
10%+ Owner |
$74.5M |
|
|
Dec 9, 2024 |
ACRV |
Acrivon Therapeutics, Inc. |
Director, 10%+ Owner |
$67.3M |
|
|
Jun 20, 2024 |
MLYS |
Mineralys Therapeutics, Inc. |
Director |
$47.7M |
|
|
May 22, 2024 |
KALA |
KALA BIO, Inc. |
10%+ Owner |
$47.4M |
|
|
May 26, 2022 |
ABOS |
Acumen Pharmaceuticals, Inc. |
Director, 10%+ Owner |
$45.3M |
|
|
Jun 10, 2024 |
CDTX |
Cidara Therapeutics, Inc. |
Director |
$35.5M |
|
|
Nov 26, 2024 |
ELVN |
Enliven Therapeutics, Inc. |
Former 10% owner |
$32.1M |
|
|
Feb 23, 2023 |
SLDB |
Solid Biosciences Inc. |
Director, 10%+ Owner |
$23.2M |
+$5M |
+27.5% |
Jan 11, 2024 |
PNT |
POINT Biopharma Global Inc. |
Director |
$13.7M |
|
|
Jun 29, 2021 |
LENZ |
LENZ Therapeutics, Inc. |
Director, 10%+ Owner |
$13.5M |
|
|
Mar 21, 2024 |
CLYM |
Climb Bio, Inc. |
Director, 10%+ Owner |
$11M |
+$50M |
|
Jun 27, 2024 |
RXST |
RxSight, Inc. |
10%+ Owner |
$10.3M |
|
|
Aug 3, 2021 |
BDTX |
Black Diamond Therapeutics, Inc. |
Director |
$8.77M |
|
|
Jul 5, 2023 |
ANTX |
AN2 Therapeutics, Inc. |
10%+ Owner |
$325K |
-$3.81M |
-92.1% |
Aug 9, 2024 |
WVE |
Wave Life Sciences Ltd. |
Director, 10%+ Owner |
$40K |
|
|
Aug 12, 2024 |
ICVX |
Icosavax, Inc. |
Director, 10%+ Owner |
$0 |
|
|
Feb 19, 2024 |
ARTV |
Artiva Biotherapeutics, Inc. |
Director, 10%+ Owner |
|
|
|
Jul 22, 2024 |
BCAX |
Bicara Therapeutics Inc. |
Director, 10%+ Owner |
|
|
|
Sep 16, 2024 |
BOLD |
Boundless Bio, Inc. |
10%+ Owner |
|
|
|
Apr 2, 2024 |
DICE |
DICE Therapeutics, Inc. |
Former 10% owners and Director |
|
|
|
Aug 9, 2023 |
FMTX |
Forma Therapeutics Holdings, Inc. |
Director, 10%+ Owner |
|
|
|
Oct 14, 2022 |
STSA |
Satsuma Pharmaceuticals, Inc. |
Former 10% Owner |
|
|
|
Jun 8, 2023 |
SEPN |
Septerna, Inc. |
Director, 10%+ Owner |
|
|
|
Oct 28, 2024 |
VOR |
Vor Biopharma Inc. |
Director, 10%+ Owner |
|
|
|
May 23, 2024 |
HOWL |
Werewolf Therapeutics, Inc. |
Director, 10%+ Owner |
|
|
|
May 24, 2024 |